Belite Bio Inc - Adr
BLTEHeld by 2 superinvestors.
SEC 10-K · fundamentals
Business quality
as of 2025-12-31- Revenue growth
- —
- Net margin
- —
- ROE
- -10.1%
- FCF margin
- —
Fundamentals data incomplete — read with care.
What makes a business high qualitySEC 13F · holders
Superinvestors Holding This Security
2 holders · $77.4M combined · this quarter +1 opened / -0 exited
- Value$61.0MWeight (prev→now)New · 0.6%
- Value$16.3MWeight (prev→now)0.6% → 0.4% ▼
SEC 13F · notes
Written summary
Written summary
Belite Bio Inc - Adr (BLTE) is held by 2 of the superinvestors tracked on Compounder, with a combined $77.4M in reported 13F value. The largest position belongs to Lee Ainslie, where it makes up 0.6% of the portfolio.
Other notable holders by value include Stanley Druckenmiller (0.4% of its book).
Over the latest quarter, 1 of the tracked filers opened a new position in BLTE, 0 added to existing ones, 0 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
SEC 13F · co-ownership
Also held by these investors
Investors holding Belite Bio Inc - Adr (BLTE) also commonly hold →
- Natera IncNTRA2 holders
- Taiwan Semiconductor-Sp AdrTSM2 holders
- Amazon.Com IncAMZN2 holders
- Advanced Micro DevicesAMD2 holders
- Insmed IncINSM2 holders
- Repligen CorpRGEN2 holders
See which stocks look cheap against a conservative value band. Browse all valued stocks
Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Stay Updated
New-quarter 13F moves and valuation updates, to your inbox.